Sfoglia per Titolo
Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040
2019-01-01 Yau, T; Kang, Yk; Kim, Ty; El-Khoueiry, Ab; Santoro, A; Sangro, B; Melero, I; Kudo, M; Hou, Mm; Matilla, A; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, Bf; Acosta-Rivera, M; Neely, J; Shen, Y; Baccan, C; Dela Cruz, Cm; Hsu, C
Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study
2019-01-01 Zinzani, Pl; Santoro, A; Gritti, G; Brice, P; Barr, Pm; Kuruvilla, J; Cunningham, D; Kline, J; Johnson, Na; Mehta-Shah, Na; Manley, T; Francis, S; Sharma, M; Moskowitz, Aj
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up
2023-01-01 Zinzani, Pier Luigi; Santoro, Armando; Gritti, Giuseppe; Brice, Pauline; Barr, Paul M; Kuruvilla, John; Cunningham, David; Kline, Justin; Johnson, Nathalie A; Mehta-Shah, Neha; Lisano, Julie M; Wen, Rachael; Akyol, Alev; Moskowitz, Alison J
Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
2023-01-01 Santoro, Armando; Moskowitz, Alison J; Ferrari, Silvia; Carlo-Stella, Carmelo; Lisano, Julie M; Francis, Stephen; Wen, Rachael; Akyol, Alev; Savage, Kerry J
Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicenter, multicohort, single-arm phase 2 trial
2016-01-01 Younes, A; Santoro, A; Shipp, M; Zinzani, P L; Timmerman, J M; Ansell, S; Armand, P; Fanale, M; Ratanatharathorn, V; Kuruvilla, J; Cohen, J B; Collins, G; Savage, K J; Trneny, M; Kato, K; Farsaci, B; Parker, S M; Rodig, S; Roemer, M G M; Ligon, A H
Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial
2018-01-01 Armand, P; Engert, A; Younes, A; Fanale, M; Santoro, A; Zinzani, P L; Timmerman, J M; Collins, G P; Ramchandren, R; Cohen, J B; De Boer, J P; Kuruvilla, J; Savage, K J; Trneny, M; Shipp, M A; Kato, K; Sumbul, A; Farsaci, B; Ansell, S M
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study
2023-01-01 Ansell, Stephen M; Bröckelmann, Paul J; von Keudell, Gottfried; Lee, Hun Ju; Santoro, Armando; Zinzani, Pier Luigi; Collins, Graham P; Cohen, Jonathon B; de Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trněný, Marek; Provencio, Mariano; Jaeger, Ulrich; Willenbacher, Wolfgang; Wen, Rachael; Akyol, Alev; Mikita-Geoffroy, Joanna; Shipp, Margaret A; Engert, Andreas Michael; Armand, Philippe
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience
2019-01-01 Rossi, S; Finocchiaro, G; Toschi, L; Santoro, A
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
2022-01-01 Yau, Thomas; Zagonel, Vittorina; Santoro, Armando; Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth; Cubillo Gracian, Antonio; El-Khoueiry, Anthony B; Sangro, Bruno; Eldawy, Tarek E; Bruix, Jordi; Frassineti, Giovanni Luca; Vaccaro, Gina M; Tschaika, Marina; Scheffold, Christian; Koopmans, Petra; Neely, Jaclyn; Piscaglia, Fabio
Nivolumab treatment beyond investigator-assessed progression: outcome in patients with relapsed/refractory classical Hodgkin Lymphoma from the phase 2 Checkmate 205 Study
2018-01-01 Cohen, J B; Engert, A; Ansell, S M; Younes, A; Trneny, M; Savage, K J; Ramchadren, R; Collins, G P; Fanale, M A; Armand, P; Zinzani, P L; De Boer, J P; Shipp, M A; Santoro, A; Timmerman, J M; Sacchi, M; Sy, O; Kuruvilla, J
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions
2021-01-01 Cazzetta, Valentina; Bruni, Elena; Terzoli, Sara; Carenza, Claudia; Franzese, Sara; Piazza, Rocco; Marzano, Paolo; Donadon, Matteo; Torzilli, Guido; Cimino, Matteo; Simonelli, Matteo; Bello, Lorenzo; Villa, Anna; Tan, Likai; Ravens, Sarina; Prinz, Immo; Supino, Domenico; Colombo, Federico S; Lugli, Enrico; Marcenaro, Emanuela; Vivier, Eric; Della Bella, Silvia; Mikulak, Joanna; Mavilio, Domenico
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer
2019-01-01 Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico
No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study
2018-01-01 Levi-Setti, P; Cirillo, F; Smeraldi, A; Morenghi, E; Mulazzani, Geg; Albani, E
No association between educational level and pancreatic cancer incidence in the European Prospective Investigation into Cancer and Nutrition
2010-01-01 van Boeckel, Pga; Boshuizen, Hc; Siersema, Pd; Vrieling, A; Kunst, Ae; Ye, Wm; Sund, M; Michaud, Ds; Gallo, V; Spencer, Ea; Trichopoulou, A; Benetou, V; Orfanos, P; Cirera, L; Duell, Ej; Rohrmann, S; Hemann, S; Masala, G; Manjer, J; Mattiello, A; Lindkvist, B; Sanchez, Mj; Pala, V; Peeters, Phm; Braaten, T; Tjonneland, A; Dalton, So; Larranaga, N; Dorronsoro, M; Overvad, K; Illner, Ak; Ardanaz, E; Marron, M; Straif, K; Riboli, E; Bueno-de-Mesquita, B
No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition
2006-01-01 Agudo, A; Sala, N; Pera, G; Capella, G; Berenguer, A; Garcia, N; Palli, D; Boeing, H; Del Giudice, G; Saieva, C; Carneiro, F; Berrino, F; Sacerdote, C; Tumino, R; Panico, S; Berglund, G; Siman, H; Stenling, R; Hallmans, G; Martinez, C; Amiano, P; Barricarte, A; Navarro, C; Quiros, Jr; Allen, N; Key, T; Bingham, S; Khaw, Kt; Linseisen, J; Nagel, G; Overvad, K; Tjonneland, A; Olsen, A; Bueno-De-Mesquita, Hb; Boshuizen, Hc; Peeters, Ph; Numans, Me; Clavel-Chapelon, F; Boutron-Ruault, Mc; Trichopoulou, A; Lund, E; Blaker, H; Jenab, M; Ferrari, P; Norat, T; Riboli, E; Gonzalez, Ca
No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC)
2017-01-01 Bergmann, Mm; Hernandez, V; Bernigau, W; Boeing, H; Chan, Ssm; Luben, R; Khaw, Kt; van Schaik, F; Oldenburg, B; Bueno-de-Mesquita, B; Overvad, K; Palli, D; Masala, G; Carbonnel, F; Boutron-Ruault, Mc; Olsen, A; Tjonneland, A; Kaaks, R; Katzke, V; Riboli, E; Hart, Ar
No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC) (vol 71, pg 512, 2017)
2017-01-01 Bergmann, Mm; Hernandez, V; Bernigau, W; Boeing, H; Chan, Ssm; Luben, R; Khaw, Kt; Schaik, Fv; Oldenburg, B; Bueno-De-Mesquita, B; Overvad, K; Palli, D; Masala, G; Carbonnel, F; Boutron-Ruault, Mc; Olsen, A; Tjonneland, A; Kaaks, R; Katzke, V; Riboli, E; Hart, Ar
No association of consumption of animal foods with risk of ovarian cancer
2007-01-01 Schulz, M; Nothlings, U; Allen, N; Onland-Moret, Nc; Agnoli, C; Engeset, D; Galasso, R; Wirfalt, E; Tjonneland, A; Olsen, A; Overvad, K; Boutron-Ruault, Mc; Chajes, V; Clavel-Chapelon, F; Rayj, J; Hoffmannj, K; Chang-Claude, J; Kaaks, R; Trichopouios, D; Georgila, C; Zourna, P; Palli, D; Berrino, F; Tumino, R; Vineis, P; Panico, S; Bueno-de-Mesquita, Hb; Ocke, Mc; Peeters, Phm; Lund, E; Gram, It; Skeie, G; Berglund, G; Lundin, E; Hallmans, G; Gonzalez, Ca; Quiros, Jr; Dorronsoro, M; Martinez, C; Tormo, Mj; Barricarte, A; Bingham, S; Khaw, Kt; Key, Tja; Jenab, M; Rinaldi, S; Slimani, N; Riboli, E
No association of GBA mutations and multiple system atrophy
2013-01-01 Srulijes, K.; Hauser, A. K.; Guella, I.; Asselta, R.; Brockmann, K.; Schulte, C.; Soldà, G.; Cilia, R.; Maetzler, W.; Schols, L.; Wenning, G. K.; Poewe, W.; Barone, P.; Wüllner, U.; Oertel, W.; Berg, D.; Goldwurm, S.; Gasser, T.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis
2014-01-01 Guerini, Fr; Clerici, M; Cagliani, R; Malhotra, S; Montalban, X; Forni, D; Agliardi, C; Riva, S; Caputo, D; Galimberti, D; Asselta, R; Fenoglio, C; Scarpini, E; Comi, Gp; Bresolin, N; Comabella, M; Sironi, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040 | 1-gen-2019 | Yau, T; Kang, Yk; Kim, Ty; El-Khoueiry, Ab; Santoro, A; Sangro, B; Melero, I; Kudo, M; Hou, Mm; Matilla, A; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, Bf; Acosta-Rivera, M; Neely, J; Shen, Y; Baccan, C; Dela Cruz, Cm; Hsu, C | |
Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study | 1-gen-2019 | Zinzani, Pl; Santoro, A; Gritti, G; Brice, P; Barr, Pm; Kuruvilla, J; Cunningham, D; Kline, J; Johnson, Na; Mehta-Shah, Na; Manley, T; Francis, S; Sharma, M; Moskowitz, Aj | |
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up | 1-gen-2023 | Zinzani, Pier Luigi; Santoro, Armando; Gritti, Giuseppe; Brice, Pauline; Barr, Paul M; Kuruvilla, John; Cunningham, David; Kline, Justin; Johnson, Nathalie A; Mehta-Shah, Neha; Lisano, Julie M; Wen, Rachael; Akyol, Alev; Moskowitz, Alison J | |
Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma | 1-gen-2023 | Santoro, Armando; Moskowitz, Alison J; Ferrari, Silvia; Carlo-Stella, Carmelo; Lisano, Julie M; Francis, Stephen; Wen, Rachael; Akyol, Alev; Savage, Kerry J | |
Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicenter, multicohort, single-arm phase 2 trial | 1-gen-2016 | Younes, A; Santoro, A; Shipp, M; Zinzani, P L; Timmerman, J M; Ansell, S; Armand, P; Fanale, M; Ratanatharathorn, V; Kuruvilla, J; Cohen, J B; Collins, G; Savage, K J; Trneny, M; Kato, K; Farsaci, B; Parker, S M; Rodig, S; Roemer, M G M; Ligon, A H | |
Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial | 1-gen-2018 | Armand, P; Engert, A; Younes, A; Fanale, M; Santoro, A; Zinzani, P L; Timmerman, J M; Collins, G P; Ramchandren, R; Cohen, J B; De Boer, J P; Kuruvilla, J; Savage, K J; Trneny, M; Shipp, M A; Kato, K; Sumbul, A; Farsaci, B; Ansell, S M | |
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study | 1-gen-2023 | Ansell, Stephen M; Bröckelmann, Paul J; von Keudell, Gottfried; Lee, Hun Ju; Santoro, Armando; Zinzani, Pier Luigi; Collins, Graham P; Cohen, Jonathon B; de Boer, Jan Paul; Kuruvilla, John; Savage, Kerry J; Trněný, Marek; Provencio, Mariano; Jaeger, Ulrich; Willenbacher, Wolfgang; Wen, Rachael; Akyol, Alev; Mikita-Geoffroy, Joanna; Shipp, Margaret A; Engert, Andreas Michael; Armand, Philippe | |
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience | 1-gen-2019 | Rossi, S; Finocchiaro, G; Toschi, L; Santoro, A | |
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial | 1-gen-2022 | Yau, Thomas; Zagonel, Vittorina; Santoro, Armando; Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth; Cubillo Gracian, Antonio; El-Khoueiry, Anthony B; Sangro, Bruno; Eldawy, Tarek E; Bruix, Jordi; Frassineti, Giovanni Luca; Vaccaro, Gina M; Tschaika, Marina; Scheffold, Christian; Koopmans, Petra; Neely, Jaclyn; Piscaglia, Fabio | |
Nivolumab treatment beyond investigator-assessed progression: outcome in patients with relapsed/refractory classical Hodgkin Lymphoma from the phase 2 Checkmate 205 Study | 1-gen-2018 | Cohen, J B; Engert, A; Ansell, S M; Younes, A; Trneny, M; Savage, K J; Ramchadren, R; Collins, G P; Fanale, M A; Armand, P; Zinzani, P L; De Boer, J P; Shipp, M A; Santoro, A; Timmerman, J M; Sacchi, M; Sy, O; Kuruvilla, J | |
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions | 1-gen-2021 | Cazzetta, Valentina; Bruni, Elena; Terzoli, Sara; Carenza, Claudia; Franzese, Sara; Piazza, Rocco; Marzano, Paolo; Donadon, Matteo; Torzilli, Guido; Cimino, Matteo; Simonelli, Matteo; Bello, Lorenzo; Villa, Anna; Tan, Likai; Ravens, Sarina; Prinz, Immo; Supino, Domenico; Colombo, Federico S; Lugli, Enrico; Marcenaro, Emanuela; Vivier, Eric; Della Bella, Silvia; Mikulak, Joanna; Mavilio, Domenico | |
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer | 1-gen-2019 | Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico | |
No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study | 1-gen-2018 | Levi-Setti, P; Cirillo, F; Smeraldi, A; Morenghi, E; Mulazzani, Geg; Albani, E | |
No association between educational level and pancreatic cancer incidence in the European Prospective Investigation into Cancer and Nutrition | 1-gen-2010 | van Boeckel, Pga; Boshuizen, Hc; Siersema, Pd; Vrieling, A; Kunst, Ae; Ye, Wm; Sund, M; Michaud, Ds; Gallo, V; Spencer, Ea; Trichopoulou, A; Benetou, V; Orfanos, P; Cirera, L; Duell, Ej; Rohrmann, S; Hemann, S; Masala, G; Manjer, J; Mattiello, A; Lindkvist, B; Sanchez, Mj; Pala, V; Peeters, Phm; Braaten, T; Tjonneland, A; Dalton, So; Larranaga, N; Dorronsoro, M; Overvad, K; Illner, Ak; Ardanaz, E; Marron, M; Straif, K; Riboli, E; Bueno-de-Mesquita, B | |
No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition | 1-gen-2006 | Agudo, A; Sala, N; Pera, G; Capella, G; Berenguer, A; Garcia, N; Palli, D; Boeing, H; Del Giudice, G; Saieva, C; Carneiro, F; Berrino, F; Sacerdote, C; Tumino, R; Panico, S; Berglund, G; Siman, H; Stenling, R; Hallmans, G; Martinez, C; Amiano, P; Barricarte, A; Navarro, C; Quiros, Jr; Allen, N; Key, T; Bingham, S; Khaw, Kt; Linseisen, J; Nagel, G; Overvad, K; Tjonneland, A; Olsen, A; Bueno-De-Mesquita, Hb; Boshuizen, Hc; Peeters, Ph; Numans, Me; Clavel-Chapelon, F; Boutron-Ruault, Mc; Trichopoulou, A; Lund, E; Blaker, H; Jenab, M; Ferrari, P; Norat, T; Riboli, E; Gonzalez, Ca | |
No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC) | 1-gen-2017 | Bergmann, Mm; Hernandez, V; Bernigau, W; Boeing, H; Chan, Ssm; Luben, R; Khaw, Kt; van Schaik, F; Oldenburg, B; Bueno-de-Mesquita, B; Overvad, K; Palli, D; Masala, G; Carbonnel, F; Boutron-Ruault, Mc; Olsen, A; Tjonneland, A; Kaaks, R; Katzke, V; Riboli, E; Hart, Ar | |
No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC) (vol 71, pg 512, 2017) | 1-gen-2017 | Bergmann, Mm; Hernandez, V; Bernigau, W; Boeing, H; Chan, Ssm; Luben, R; Khaw, Kt; Schaik, Fv; Oldenburg, B; Bueno-De-Mesquita, B; Overvad, K; Palli, D; Masala, G; Carbonnel, F; Boutron-Ruault, Mc; Olsen, A; Tjonneland, A; Kaaks, R; Katzke, V; Riboli, E; Hart, Ar | |
No association of consumption of animal foods with risk of ovarian cancer | 1-gen-2007 | Schulz, M; Nothlings, U; Allen, N; Onland-Moret, Nc; Agnoli, C; Engeset, D; Galasso, R; Wirfalt, E; Tjonneland, A; Olsen, A; Overvad, K; Boutron-Ruault, Mc; Chajes, V; Clavel-Chapelon, F; Rayj, J; Hoffmannj, K; Chang-Claude, J; Kaaks, R; Trichopouios, D; Georgila, C; Zourna, P; Palli, D; Berrino, F; Tumino, R; Vineis, P; Panico, S; Bueno-de-Mesquita, Hb; Ocke, Mc; Peeters, Phm; Lund, E; Gram, It; Skeie, G; Berglund, G; Lundin, E; Hallmans, G; Gonzalez, Ca; Quiros, Jr; Dorronsoro, M; Martinez, C; Tormo, Mj; Barricarte, A; Bingham, S; Khaw, Kt; Key, Tja; Jenab, M; Rinaldi, S; Slimani, N; Riboli, E | |
No association of GBA mutations and multiple system atrophy | 1-gen-2013 | Srulijes, K.; Hauser, A. K.; Guella, I.; Asselta, R.; Brockmann, K.; Schulte, C.; Soldà, G.; Cilia, R.; Maetzler, W.; Schols, L.; Wenning, G. K.; Poewe, W.; Barone, P.; Wüllner, U.; Oertel, W.; Berg, D.; Goldwurm, S.; Gasser, T. | |
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis | 1-gen-2014 | Guerini, Fr; Clerici, M; Cagliani, R; Malhotra, S; Montalban, X; Forni, D; Agliardi, C; Riva, S; Caputo, D; Galimberti, D; Asselta, R; Fenoglio, C; Scarpini, E; Comi, Gp; Bresolin, N; Comabella, M; Sironi, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile